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Background: Setting priorities for the prevention and management of heart failure requires an empirical
understanding of the pattern of disease burden. We aim to describe the methods for a systematic review of the
literature on burden of heart failure in low- and middle-income countries (LMIC) and how this information will be
synthesized to produce useful estimates that can inform policy and practice.
Methods: We will conduct a comprehensive search strategy for articles published between 1995 and April 2012
related to incidence, prevalence and treatment of heart failure in LMIC. Populations will be coded as urban, rural, or
combined and studies classified as national, sub-national, healthcare system-based, or community level. Details from
eligible studies will be extracted independently by two reviewers using a pre-designed data extraction form that
will cover information on demographics, diagnostic criteria including disease incidence and prevalence, medical
history, medication history, and hospital- or community-based management and outcomes. We will assess the
reporting and methodological quality of the included studies and conduct a quantitative summary of reported
outcomes where appropriate.
Discussion: Currently, there are important gaps in our knowledge on the burden of heart failure in LMIC and this
systematic review aims to provide useful information that improves our knowledge in this field. Results are
expected to be publicly available in early 2013.
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The increasing prevalence of heart failure is a recognized
major public health issue in most high-income countries
[1,2]. For instance, in the UK, about 1% of the popula-
tion suffers from chronic heart failure but the prevalence
increases rapidly with age, affecting about 7% of the
population aged 75 years or more [3]. Heart failure is
already one of the leading causes of admission to, and
bed occupancy in, UK hospitals, surpassing all other car-
diac conditions [3]. Incidence and prevalence of heart
failure in other developed countries are similar to those* Correspondence: kazem.rahimi@georgecentre.ox.ac.uk
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reproduction in any medium, provided the orin the UK, rendering it a great burden to health services
and patients in high-income countries [4,5].
More recently, cardiovascular disease has become one
of the major causes of premature death and disability in
low- and middle-income countries (LMIC). While this is
expected to lead to a growing burden of heart failure in
such countries, there is little systematic data about inci-
dence, prevalence, underlying causes, and management
of heart failure in these regions [6-8]. For example, a re-
view conducted in 2000 found no published population-
based studies of heart failure in the developing world
and only very limited information from case series and
hospital-based studies [6].
We aim to fill this gap in knowledge by conducting a
systematic review of the contemporary literature on the
‘burden’ of heart failure from less developed countries.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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beyond other recent reports, which focused on regional
variation in heart failure epidemiology worldwide [5].
Objectives
The overall aim of this paper is to present a transparent
process for how the information will be collected on the
burden of heart failure in LMIC. This will be based on ex-
plicit definitions and summarize the techniques that will
be used to maximize the validity of these measurements by
addressing bias, confounding, and missing data. More spe-
cifically, we aim to: describe the key research questions that
this review will address; document our systematic literature
search strategy; describe criteria for inclusion or exclusion
of studies and other data sources identified in the review;
describe study coding procedures, data categorizations,
and study quality measures for the systematic review; and
describe statistical procedures for the quantitative analysis
of data from eligible studies.
Methods
Diagnosis of heart failure and the role of diagnostic testing
Heart failure is not a distinct disease but a syndrome
with several potential underlying causes and precipi-
tants, such as myocardial infarction, valve disease, or
non-cardiac conditions. Once diagnosis has been estab-
lished, further investigations are usually required to elicit
the underlying cause of the heart failure. Commonly,
diagnosis is based on a combination of clinical examin-
ation, electrocardiogram, chest X-ray, echocardiography,
and blood concentrations of natriuretic peptides (Brain
Natriuretic Peptide or N-terminal pro-B type natriuretic
peptide levels) [7]. The availability of these tests and the
approach to diagnosis of heart failure are likely to be
highly variable in different settings. In the current study,
we will not restrict studies to a particular case definition.
Instead we will record the diagnostic criteria used for
case definition in each study and will then assess its
quality according to international guidelines for diagno-
sis of heart failure [7].
Research questions
Our literature review aims to address the following re-
search questions. In LMIC,
1. What is the contemporary incidence and prevalence
of heart failure?
2. What are the common causes or determinants of
heart failure?
3. What is the burden of heart failure to health
services, in terms of proportion of admissions to
hospital, length of stay and resource utilization?
4. How are patients with heart failure diagnosed and
managed?These questions are highly relevant to policy makers
and service providers. However, addressing these ques-
tions requires reviewing different types of literature. In-
formation about incidence and prevalence of heart
failure can be extracted from population-based cohort
or cross-sectional studies, whereas resource utilization
and management of heart failure patients is usually
reported in hospital-based or provider-based studies.
The need for consideration of different study designs
and settings is reflected in our search strategy and eligi-
bility criteria.
Study eligibility
Studies among any population(s) from throughout the
world are potentially eligible for inclusion in this over-
view if they satisfy all the following criteria: population-
based cohort study, or registries and hospital databases,
or cross-sectional studies such as census data; sample
size restricted to more than 100 cases of heart failure as
defined by the authors; for population-based cohort or
cross-sectional studies: reports on incidence or preva-
lence (by age, gender and so on.); for hospital-based co-
hort or cross-sectional studies: reports on proportion of
heart failure admissions to total admissions (prevalence),
causes or underlying reasons, death and readmission rates
(for example, in hospital, 30-day, or annual rates), length of
stay, and/or management (such as prescription rates); geo-
graphic regions confined to LMICs in Sub-Saharan Africa,
Mediterranean region (excluding Europe), Central and
Latin America, South, South East, South West, and Central
Asia, and China.
Studies confined to subgroups of patients with heart
failure (for example, with dilated cardiomyopathy or
heart failure as a complication of acute myocardial in-
farction) will be excluded, as will studies that do not in-
clude a representative sample of patients (for example,
studies that selected people referred to a echocardiog-
raphy department). We aim to report information at in-
dividual country or regional level. Investigators of
multinational studies that have not reported findings by
each country or region will be contacted for provision of
region- or country-specific data.
Search strategy for identification of relevant studies
As we are primarily interested in the contemporary litera-
ture on this topic, we will search MEDLINE, Embase, Glo-
bal Health Database (formerly CAB abstracts), and World
Health Organization regional databases) for articles pub-
lished between 1995 and April 2012 with any of the subject
terms “heart failure” and “cardiomyopathies” or any of the
following terms in the title or abstract: ‘heart failure’, ‘cardi-
omyopath*’, ‘cardiac failure’ AND ‘incidence’, ‘prevalence’,
‘cause*’, ‘etiology’, ‘aetiology’, ‘epidemiolog*’, ‘burden’, ‘manage-
ment’, ‘treatment’, ‘prevent*’, ‘population based’, ‘community’,
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or ‘attack rate’. The search will further be limited to regions
outside Europe and North America and to human studies
with no language restriction. We will also scrutinize the
reference lists of study reports and review articles, and
inquire among collaborators and colleagues.
Screening of abstracts
After removing duplicate reports, two reviewers will in-
dependently screen all titles and abstracts for their po-
tential eligibility as described previously. Specifically,
titles and abstracts are included if they indicated that it
was a population-based or hospital-based study report-
ing any relevant information on incidence, prevalence,
case-fatality or mortality, or management and outcomes
of patients with heart failure in a well-specified popula-
tion. Studies might be based on cohorts, cross-sectional
surveys, disease registry, hospital surveys, or notification
data. The list of all titles and abstracts identified will
provide a pool of the epidemiological evidence-base for
heart failure in LMIC. In the next stage, members of the
review team will identify all studies that potentially meet
the eligibility criteria that provided the most relevant
data for the measures of interests. Full reports of these
citations will be obtained for further assessment of the
study for inclusion in the systematic review. In the third
stage, we will categorize the available information by re-
gion and will contact local experts for any additional in-
formation that they may be aware of. If there are reports
from a country or region covering multiple time-points,
we aim to use either the most up-to-date or the most
robust information available.
Data extraction
Details from eligible studies will be extracted independ-
ently by two reviewers using a pre-designed data extrac-
tion form. Where the data that is extracted differ
between assessors, the discrepancy will be resolved by
consensus and, when necessary, additional information
will be sought from the authors of the studies. Where
differences in opinion still exist, a third party will be
consulted. The data extraction form will include the fol-
lowing items:
General information: Name of study, country, or
region where study was conducted, year of publication,
journal, language of publication, contact address of
corresponding author.
Reason for exclusion: Irrelevant geographic region, less
than 100 cases, no relevant information about disease
burden, management, or outcomes.
Population characteristics: Demographic details (for the
overall population and for the cases separately), for
example, age, gender, and ethnicity.Case definition and description: Diagnostic criteria and
investigations used, including any details on specific
measures such as laboratory information (for example,
biomarkers), electrocardiogram, chest X-ray, or
echocardiographic findings.
Causes of heart failure and any other relevant co-
morbidities: History of coronary artery disease,
hypertension, diabetes, valve disease, rheumatic heart
disease, atrial fibrillation, renal failure, cardiomyopathy,
chronic obstructive lung disease, or smoking.
Medication history: Percentage use of aspirin, warfarin,
diuretics, beta-blockers, angiotensin-converting
enzyme-inhibitors, or angiotensin-receptor blockers,
percentage of other relevant medications or device
therapies.
Hospital-based study outcomes: Proportion of cases to
the total number of population included in the study
(prevalence), duration of stay, mortality rate,
readmission rate, prevalence of medications at
discharge from hospital.
Community-based study outcomes: Incidence,
prevalence, mortality rate, prevalence of medication use
in the community.
Methodological information: Study design, urban or
rural population, completeness of case ascertainment,
representativeness, validity of case ascertainment,
reliability of outcome data.
Quality assessment
We will separate out methodological quality from gen-
eral reporting quality as it is important to clarify and dif-
ferentiate between quality of reporting and the quality of
what was actually done (that is, a study could be well
reported but have methodological limitations or vice
versa) [9]. As a variety of study types and data sources
are likely to be eligible from the heart failure literature,
information will be recorded on the appropriateness of
the particular study design to estimate relevant disease
parameters; whether the data are representative of the
population; and methodological quality and complete-
ness of data reported. Methodological quality refers to
the extent to which specific aspects of a study or data
source can be shown to protect against systematic bias,
non-systematic bias, and inferential error for the out-
comes of interest.
We intend to assess the general reporting quality of the
study using a selection of items derived from those
included in the Strengthening the Reporting of Observa-
tional Epidemiology statement for assessing the quality of
observational studies [10]. We will assess specific items of
reporting quality, such as use of a clear definition of heart
failure; that the design and methods are appropriate for the
research question; that the sample size is adequate for
robust estimates; that the denominator data are reliable
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riance estimates are reported (or can be derived from the
information reported); that the sources of potential bias are
adequately controlled; and that the study limitations that
can influence interpretation of findings are identified.
The collection of this general reporting quality infor-
mation as well as methodologically-specific quality infor-
mation enables the exploration of possible sources of
heterogeneity and will also be used to conduct sensitivity
analyses to quantify the magnitude of possible bias in
study estimates based on particular characteristics of the
study. Sensitivity analyses will be based on stratification
by individual items of methodological quality or (where
appropriate) individual items of general reporting quality
to assess the robustness of the findings.
Quantitative synthesis of individual estimates
It is envisaged that many of the studies will report their
results as either numbers of participants or as a percent-
age of the total population for many of the outcomes of
interest (for example, incident heart failure, co-morbidities,
types of investigations performed, and discharge medica-
tion). It should be possible to derive appropriate point
estimates and measures of variability from this type of in-
formation if an appropriate denominator is available. For3275 abstracts reviewe
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potentially relevant
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X studies to be
included in the
final report
Figure 1 Search retrieval process.continuous outcomes, such as length of stay, if a standard
deviation is not reported, it is possible to derive an estimate
of the variability based on the range [11].
The individual study estimates extracted will be com-
bined using inverse-variance weighting techniques to
provide information on the relevant estimates of inci-
dence, prevalence, and other relevant outcomes (if this is
appropriate). This implies that larger studies will be
given more weight in the analyses when producing an
overall pooled estimate for a particular low- or middle-
income country. This approach is more robust to small
study biases (of which publication bias is just one of as-
pect of this umbrella term) [12]. We will investigate po-
tential sources of heterogeneity (as assessed by the
standard Cochrane Q statistics and the I-squared statis-
tic that can be derived from the Cochrane’s Q), related
to both methodological and clinical characteristics of the
studies [13]. We will also aim to investigate whether
there is effect modification in particular subgroups such
as by age, sex, region, and ethnicity if we have sufficient
information available [14].
Preliminary report
Figure 1 summarizes the retrieval and selection process for
studies. The combined searches yielded 3,275 reports, of3030 reports excluded based
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abstracts. Full text articles are currently being retrieved for
210 potentially relevant studies. In addition, 35 reviews or
commentary articles relating to heart failure burden or
management in LMIC have been identified. These articles
are currently being reviewed for any potentially relevant
reference that they may contain. An electronic data extrac-
tion form has been piloted (the form can be obtained from
the corresponding author upon request), and full text data
extraction will begin once all potentially full text articles
have been retrieved.
Discussion
Ageing populations with an increasing prevalence of
heart failure place a growing burden on health systems
in many parts of the world. Crude estimates based on lim-
ited data suggest that heart failure may have become the
most rapidly growing cardiovascular condition worldwide
in terms of the absolute number of cases diagnosed each
year [15]. Heart failure is associated with substantial mor-
bidity and mortality [1,2] and is one of the leading causes
of admission to hospital in many high-income countries
[15]. However, there are currently important gaps in our
knowledge on the incidence and prevalence of heart fai-
lure and management patterns for such patients in coun-
tries outside North America and Europe [8]. Setting
priorities in service delivery for the prevention and treat-
ment of heart failure requires an empirical understanding
of the pattern of disease burden. This systematic review
aims to provide useful information that improves our
knowledge in this field. We expect this review to fill the
gap in knowledge in burden of disease in LMIC [6] and to
extend recent work in the areas of management practices
and impact on health services [5]. This new information
should be able to form the basis of an evidence-base for
policy and practice in these regions. Currently, we have
screened over 3,000 abstracts and identified about 200 po-
tentially relevant studies, which will be subject to full text
review. We expect data extraction to be completed by the
end of 2012. Preliminary analyses will be conducted by
the end of the first quarter of 2013. Results are expected
to be publicly available by mid-2013.
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